Temafloxacin in the treatment of male urethritis

Keizo Suzuki, Masaki Horiba, Toshiyuki Tanaka, Masahiro Yonezu, Yorio Naide, Hideo Hibi, Shin Ichi Ando, Koichi Ishiguro, Haruyoshi Asano, Kiyohito Ishikawa

Research output: Contribution to journalArticle


Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.

Original languageEnglish
Pages (from-to)843-845
Number of pages3
Publication statusPublished - 1993

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology
  • Drug Discovery
  • Oncology

Fingerprint Dive into the research topics of 'Temafloxacin in the treatment of male urethritis'. Together they form a unique fingerprint.

  • Cite this

    Suzuki, K., Horiba, M., Tanaka, T., Yonezu, M., Naide, Y., Hibi, H., Ando, S. I., Ishiguro, K., Asano, H., & Ishikawa, K. (1993). Temafloxacin in the treatment of male urethritis. CHEMOTHERAPY, 41, 843-845. https://doi.org/10.11250/chemotherapy1953.41.Supplement5_843